# Yoshinobu Saito

> Yoshinobu Saito is listed as Assistant Professor at The University of Osaka, recorded in ORCID since 2023. Their published research is indexed in Medicine, specifically Epidemiology, across 99 works listed on their ORCID profile. OpenAlex records an h-index of 20 and 2,222 citations across 98 indexed publications. Recent indexed output includes “Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage” (2026) and “Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in…” (2026). Their ORCID profile self-asserts 5 employment records and 1 education record.

*Source: [https://selltoscientists.com/researchers/yoshinobu-saito/](https://selltoscientists.com/researchers/yoshinobu-saito/)*

**Institution:** The University of Osaka
**Field:** Medicine
**H-index:** 20
**Publications:** 98
**ORCID:** `0000-0002-0624-0449`

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product